David Linetsky Sells 1,100 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 1,100 shares of the business’s stock in a transaction that occurred on Friday, October 18th. The shares were sold at an average price of $20.49, for a total value of $22,539.00. Following the completion of the transaction, the senior vice president now owns 200,207 shares of the company’s stock, valued at $4,102,241.43. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

David Linetsky also recently made the following trade(s):

• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $24.04, for a total transaction of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The stock was sold at an average price of $24.77, for a total transaction of $891.72.
• On Tuesday, September 10th, David Linetsky sold 1,716 shares of Phreesia stock. The shares were sold at an average price of $23.25, for a total value of $39,897.00.

Phreesia Trading Down 1.4 %

Shares of Phreesia stock opened at $18.15 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. The business has a fifty day simple moving average of $23.07 and a two-hundred day simple moving average of $22.35. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $29.16. The company has a market capitalization of $1.05 billion, a price-to-earnings ratio of -10.08 and a beta of 0.93.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The firm had revenue of $102.12 million during the quarter, compared to the consensus estimate of $101.76 million. Research analysts forecast that Phreesia, Inc. will post -1.23 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on PHR shares. Canaccord Genuity Group reiterated a “buy” rating and set a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. JPMorgan Chase & Co. raised their price target on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, September 9th. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. JMP Securities restated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Finally, Truist Financial lifted their target price on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, September 6th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $29.42.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently added to or reduced their stakes in PHR. Vanguard Group Inc. lifted its position in shares of Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock worth $107,148,000 after buying an additional 194,035 shares during the last quarter. Capital International Investors raised its stake in Phreesia by 221.1% during the first quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock worth $62,052,000 after acquiring an additional 1,785,463 shares in the last quarter. Champlain Investment Partners LLC bought a new position in shares of Phreesia in the first quarter worth about $29,941,000. Blair William & Co. IL boosted its stake in shares of Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after purchasing an additional 224,950 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC grew its holdings in shares of Phreesia by 4.5% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 447,638 shares of the company’s stock valued at $10,712,000 after purchasing an additional 19,454 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.